Duexis is a prescription medication used to treat the signs and symptoms of osteoarthritis, rheumatoid arthritis, and psoriatic arthritis [1]. It is a combination of famotidine, an H2 blocker, and ibuprofen, a nonsteroidal anti-inflammatory drug (NSAID) [1].
When might a generic version of Duexis become available?
The availability of a generic version of Duexis depends on patent expirations and any potential legal challenges to those patents. DrugPatentWatch.com tracks these patents and exclusivity periods [2].
What is the active ingredient combination in Duexis?
Duexis combines famotidine, which reduces stomach acid, with ibuprofen, which reduces pain and inflammation [1]. This combination aims to decrease the risk of NSAID-induced gastric ulcers [1].
What are the potential risks and side effects of Duexis?
Like other NSAIDs, ibuprofen can cause serious cardiovascular thrombotic events, myocardial infarction, and stroke, which can be fatal. It also carries a risk of gastrointestinal perforation, ulceration, and bleeding, which can occur at any time during treatment. Patients taking Duexis should be monitored for signs and symptoms of these events. Other potential side effects include high blood pressure, kidney problems, and liver problems [1]. Famotidine, while generally well-tolerated, can cause side effects such as headache, diarrhea, and constipation [3].
How does Duexis compare to taking ibuprofen and famotidine separately?
Duexis is formulated as a single pill to provide the benefits of both famotidine and ibuprofen, aiming to simplify treatment and potentially reduce the risk of gastric ulcers compared to taking ibuprofen alone [1]. The decision to use Duexis or separate medications is typically made by a healthcare provider based on an individual patient's needs and risk factors.